Next 10 |
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
2024-05-13 07:59:56 ET Summary JAKKS Pacific's Q1 2024 results show mixed performance, with revenue of $90.1M (12% higher than expected) but adjusted EPS of -$1.09 (28% worse than expected). The company had previously anticipated weak results for the first half of 2024 due to a la...
2024-05-11 19:05:39 ET Solo Brands, Inc (DTC) Q1 2024 Results Conference Call May 9, 2024 08:30 AM ET Company Participants Bruce Williams - Investor Relations Chris Metz - President, Chief Executive Officer & Director Laura Coffey - Chief Financial Officer ...
2024-05-09 10:53:08 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Solo Brands (NYSE: DTC ) just reported results for the first quarter of 2024. Solo Brands reported earnings per share of 3 cents. The company reported revenue of $85.3...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
2024-05-09 06:54:03 ET More on Solo Brands Solo Brands: New CEO Hoping To Reignite Growth Solo Brands: I'm Expecting Further Financial Turbulence In 2024 Solo Brands Non-GAAP EPS of $0.13 misses by $0.04, revenue of $165.32M misses by $0.83M Seeking Alpha...
Reaffirms Full Year 2024 Guidance Solo Brands, Inc. (NYSE: DTC) (“Solo Brands” or “the Company”) today announced its financial results for the three month period ended March 31, 2024. “We are pleased with our first quarter results as sales and adju...
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce...
Solo Brands, Inc (NYSE: DTC), ("Solo Brands" or the "Company"), an omni-channel platform of beloved brands Solo Stove , Chubbies , Oru Kayak , ISLE , TerraFlame , and IcyBreeze today announced that it plans to report its first quarter fiscal 2024 financial results on May 9...
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...
News, Short Squeeze, Breakout and More Instantly...
Solo Brands Inc. Class A Company Name:
DTC Stock Symbol:
NYSE Market:
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...